Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study
Open Access
- 14 June 2022
- journal article
- research article
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 7 (6) , 104
Abstract
Compliance with medication in persons with diabetes mellitus (DM) has been a challenge during the COVID-19 pandemic, leading to poor glycemic control and higher risk of complications. In the state of Kerala, India, 20–25% of adults have DM. Our cross-sectional study aimed to assess medication compliance and factors associated with poor compliance in DM persons attending selected primary care government facilities in Kerala during the COVID-19 pandemic. Persons registered with DM for >6 months were consecutively interviewed between August and September 2021. Poor compliance was defined as answering “No” to one or more of three questions related to access and intake of medication two weeks prior to and the day before the interview. Factors independently associated with poor compliance were assessed using adjusted prevalence ratios (aPr) and 95% confidence intervals. Of the 560 DM persons included, 209 (37%) exhibited poor compliance. Factors associated with poor compliance were age 19–45 years (aPr 1.4, 1.1–1.9); inability to be blood glucose tested during the COVID-19 pandemic (aPr 3.6, 2.9–4.3); not having COVID-19 (aPr 1.4, 1.0–1.9); and being double vaccinated against COVID-19 (aPr 1.4, 1.1–2.0). Focused attention must be paid to these groups to improve medication compliance and prevent DM complications and severe COVID-19-related disease.Keywords
Funding Information
- WHO/SEARO
- TDR
This publication has 20 references indexed in Scilit:
- Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysisThe Lancet, 2020
- Commentary: COVID-19 in patients with diabetesMetabolism, 2020
- Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 DiabetesCell Metabolism, 2020
- Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease StudyThe Lancet, 2017
- Type 2 diabetesThe Lancet, 2017
- Medication adherence in patients with diabetes mellitus: does physician drug dispensing enhance quality of care? Evidence from a large health claims database in SwitzerlandPatient Preference and Adherence, 2016
- Tuberculosis infection control measures in diabetes clinics in China: a rapid assessment of 10 hospitalsTropical Medicine & International Health, 2015
- The Adherence to Medications in Diabetic Patients in Rural Kerala, IndiaAsia Pacific Journal of Public Health, 2013
- Retracted: Predictive Validity of a Medication Adherence Measure in an Outpatient SettingThe Journal of Clinical Hypertension, 2008
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008